Table 1:
Baseline characteristics of 554 participants with minimal change disease, including those with childhood-onset disease (age ≤12), adolescent-onset disease (age 13-17) and adult-onset disease (age ≥18 years).
| Child at Disease Onset (n=304) |
Adolescent at Disease Onset (n=49) |
Adult at Disease Onset (n=201) |
P-value | |
|---|---|---|---|---|
| Female, n(%) | 118 (39%) | 21 (43%) | 120 (60%) | <0.001 |
| Age at Disease Onset (years) | 4.0 (2.0-6.0) | 15.0 (14.0-16.0) | 43.0 (28.0-57.0) | <0.001 |
| Age at Biopsy (years) | 5.0 (3.0-9.0) | 15.0 (14.0-16.0) | 44.0 (30.0-58.0) | <0.001 |
| Incident Cohort, n(%) | 101 (33%) | 21 (43%) | 65 (32%) | 0.4 |
| Race, n(%)a | 0.40 | |||
| White/Caucasian | 193 (63%) | 30 (61%) | 138 (69%) | |
| Black/African American | 58 (19%) | 12 (24%) | 27 (13%) | |
| Asian | 21 (7%) | 5 (10%) | 23 (11%) | |
| Other | 20 (7%) | 1 (2%) | 5 (2%) | |
| Ethnicity: Hispanic/Latino n(%) | 38 (13%) | 4 (8%) | 19 (10%) | 0.4 |
| Insurance, n(%) | <0.001 | |||
| Private Insurance | 117 (38%) | 24 (49%) | 143 (71%) | |
| Public Insurance (US) | 120 (39%) | 14 (29%) | 30 (15%) | |
| Public Insurance (non-US) | 37 (12%) | 7 (14%) | 16 (8%) | |
| Other Insurance | 15 (5%) | 1 (2%) | 7 (3%) | |
| No Insurance | 3 (1%) | 1 (2%) | 3 (1%) | |
| Overweight/Obese, n (%) | 166 (55%) | 23 (47)% | 133 (66%) | 0.02 |
| Country, n (%) | 0.002 | |||
| United States | 264 (87%) | 41 (84%) | 173 (86%) | |
| Canada | 15 (5%) | 4 (8%) | 20 (10%) | |
| Italy | 21 (7%) | 4 (8%) | 1 (1%) | |
| Poland | 4 (1%) | 0 (0%) | 7 (3%) | |
| Median Follow up time (years, IQR) | 3.2 (2.1,4.4) | 2.7 (1.8,4.1) | 2.7 (1.6,3.9) | 0.008 |
a
Race Unknown, total n = 21
N(%) or mean (standard deviation) or median (IQR).